343 related articles for article (PubMed ID: 25750558)
1. Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir.
Jo YJ; Kim KA; Lee JS; Kim NH; Bae WK; Song TJ; Kim JW
Korean J Intern Med; 2015 Mar; 30(2):170-6. PubMed ID: 25750558
[TBL] [Abstract][Full Text] [Related]
2. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
3. Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.
Chon YE; Kim SU; Lee CK; Heo J; Kim JK; Yoon KT; Cho M; Lee KS; Kim DH; Choi EH; Park JY; Kim DY; Chon CY; Han KH; Ahn SH
Antivir Ther; 2011; 16(4):469-77. PubMed ID: 21685534
[TBL] [Abstract][Full Text] [Related]
4. Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B.
Koffi J; Egounlety R; Pradat P; Lebosse F; Si-Ahmed SN; Lussier V; Chevallier P; Bailly F; Zoulim F
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):146-54. PubMed ID: 24025974
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy.
Chen CH; Hu TH; Hung CH; Wang JH; Lu SN; Lee CM
J Viral Hepat; 2014 Aug; 21(8):e55-64. PubMed ID: 24766327
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir.
Choi HN; Song JE; Lee HC; Jo HH; Lee CH; Kim BS
Clin Mol Hepatol; 2015 Mar; 21(1):24-31. PubMed ID: 25834799
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.
Lok AS; Trinh H; Carosi G; Akarca US; Gadano A; Habersetzer F; Sievert W; Wong D; Lovegren M; Cohen D; Llamoso C
Gastroenterology; 2012 Sep; 143(3):619-628.e1. PubMed ID: 22643350
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy.
Ko SY; Choe WH; Kwon SY; Kim JH; Seo JW; Kim KH; Lee CH
Scand J Gastroenterol; 2012 Nov; 47(11):1362-7. PubMed ID: 22934534
[TBL] [Abstract][Full Text] [Related]
9. Clinical and virological outcomes of entecavir therapy in patients with chronic hepatitis B: A real life experience.
Aljumah AA; Bin Selayem NA; Al-Howti SY; Dafallah M; AlGhamdi H; Mokhtar H; Albekairy AM; Sanai FM
J Infect Chemother; 2019 Jan; 25(1):12-16. PubMed ID: 30366861
[TBL] [Abstract][Full Text] [Related]
10. Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity.
Li X; Li F; Zhang Y; Kang Y; Yu J; Yang F; Liu H; Qin Y; Huang Y; Mao R; Zhang J
Biochem Biophys Res Commun; 2015 Sep; 464(4):1185-1191. PubMed ID: 26212437
[TBL] [Abstract][Full Text] [Related]
11. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.
Yang SC; Lee CM; Hu TH; Wang JH; Lu SN; Hung CH; Changchien CS; Chen CH
J Antimicrob Chemother; 2013 Sep; 68(9):2154-63. PubMed ID: 23620466
[TBL] [Abstract][Full Text] [Related]
12. Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
Chaung KT; O'Brien C; Ha NB; Nguyen NH; Trinh HN; Nguyen MH
J Clin Gastroenterol; 2016 Apr; 50(4):338-44. PubMed ID: 26646801
[TBL] [Abstract][Full Text] [Related]
13. Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication.
Kamezaki H; Kanda T; Wu S; Nakamoto S; Arai M; Maruyama H; Fujiwara K; Imazeki F; Yokosuka O
Scand J Gastroenterol; 2011 Sep; 46(9):1111-7. PubMed ID: 21623676
[TBL] [Abstract][Full Text] [Related]
14. Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological response.
Zoutendijk R; Reijnders JG; Brown A; Zoulim F; Mutimer D; Deterding K; Petersen J; Hofmann WP; Buti M; Santantonio T; van Bömmel F; Pradat P; Oo Y; Luetgehetmann M; Berg T; Hansen BE; Wedemeyer H; Janssen HL;
Hepatology; 2011 Aug; 54(2):443-51. PubMed ID: 21563196
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B.
Park JH; Ahn SJ; Cho HJ; Kim SS; Cheong JY; Cho SW
J Med Virol; 2016 Feb; 88(2):252-9. PubMed ID: 26178822
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
17. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment.
Wang X; Zhang C; Zhu Y; Xiong Y; Wang Y
Antiviral Res; 2014 Mar; 103():71-7. PubMed ID: 24462954
[TBL] [Abstract][Full Text] [Related]
19. Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
Fong TL; Tien A; Jo KJ; Chu D; Cheung E; Mena EA; Phan QQ; Yu AS; Mohammed W; Velasco A; LeDuc VH; Nguyen N; Han SB; Chang M; Bae HS; Cho YW; Tong MJ; Cooper SL
Dig Dis Sci; 2015 Nov; 60(11):3465-72. PubMed ID: 26138653
[TBL] [Abstract][Full Text] [Related]
20. Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.
Leung N; Peng CY; Hann HW; Sollano J; Lao-Tan J; Hsu CW; Lesmana L; Yuen MF; Jeffers L; Sherman M; Min A; Mencarini K; Diva U; Cross A; Wilber R; Lopez-Talavera J
Hepatology; 2009 Jan; 49(1):72-9. PubMed ID: 19065670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
